“BPC-157 heals everything.”

BPC-157 has a real, describable mechanism, which is more than a lot of the internet's favorite compounds can say. Its clearest effect is promoting angiogenesis — new blood-vessel growth, largely via the VEGF pathway — plus support for the gut lining and soft tissue. That's a legitimate reason people run it for tendons, ligaments, and GI complaints.

The problem is the leap from 'helps soft-tissue repair' to 'heals everything.' The two aren't the same claim, and the gap between them is where disappointment lives. Much of the strongest evidence is still preclinical — animal models and mechanism studies rather than large human trials — and a compound that supports the biology of repair is not a universal fix for every injury, condition, or ache.

There's also a quieter cost to the cure-all framing: it encourages people to lean on the peptide instead of doing the unglamorous work that actually heals tissue — progressive loading, sleep, protein, time. BPC-157 can support that process. It can't replace it, and treating it as a shortcut tends to stall the very recovery it's meant to help.

Held to its real lane — a plausible soft-tissue recovery aid, often paired with TB-500 — it's a useful tool. Held up as magic, it's a setup for a letdown.